3 results
Approved WMOCompleted
"The primary objective of this study is to compare the clinical therapeutic effects of intravenous DP-b99 at adose of 1.0 mg/kg initiated within nine hours of stroke onset and administered daily over 2 hours for 4consecutive days versus placebo…
Approved WMOCompleted
The purpose of the study is to evaluate the efficacy and safety of Cevira® compared to placebo in treatment of patients with cervical histologic HSIL.
Approved WMOCompleted
To evaluate the relationships between BIS* parameters, age, and depth of anesthesia in patients undergoing surgery under general anesthesia.